T2 Biosystms Probability of Future Pink Sheet Price Finishing Under 0.5

TTOODelisted Stock  USD 0.18  0.05  21.74%   
T2 Biosystms' future price is the expected price of T2 Biosystms instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of T2 Biosystms performance during a given time horizon utilizing its historical volatility. Check out T2 Biosystms Backtesting, T2 Biosystms Valuation, T2 Biosystms Correlation, T2 Biosystms Hype Analysis, T2 Biosystms Volatility, T2 Biosystms History as well as T2 Biosystms Performance.
  
Please specify T2 Biosystms' target price for which you would like T2 Biosystms odds to be computed.

T2 Biosystms Target Price Odds to finish below 0.5

The tendency of TTOO Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under $ 0.50  after 90 days
 0.18 90 days 0.50 
about 87.3
Based on a normal probability distribution, the odds of T2 Biosystms to stay under $ 0.50  after 90 days from now is about 87.3 (This T2 Biosystms probability density function shows the probability of TTOO Pink Sheet to fall within a particular range of prices over 90 days) . Probability of T2 Biosystms price to stay between its current price of $ 0.18  and $ 0.50  at the end of the 90-day period is about 74.68 .
Given the investment horizon of 90 days T2 Biosystms has a beta of -0.58. This usually implies as returns on the benchmark increase, returns on holding T2 Biosystms are expected to decrease at a much lower rate. During a bear market, however, T2 Biosystms is likely to outperform the market. Additionally T2 Biosystms has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   T2 Biosystms Price Density   
       Price  

Predictive Modules for T2 Biosystms

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as T2 Biosystms. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.010.1822.02
Details
Intrinsic
Valuation
LowRealHigh
0.010.1722.01
Details
Naive
Forecast
LowNextHigh
00.2522.08
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.070.180.30
Details

T2 Biosystms Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. T2 Biosystms is not an exception. The market had few large corrections towards the T2 Biosystms' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold T2 Biosystms, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of T2 Biosystms within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.18
β
Beta against Dow Jones-0.58
σ
Overall volatility
0.14
Ir
Information ratio -0.0068

T2 Biosystms Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of T2 Biosystms for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for T2 Biosystms can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
T2 Biosystms generated a negative expected return over the last 90 days
T2 Biosystms has high historical volatility and very poor performance
T2 Biosystms has some characteristics of a very speculative penny stock
T2 Biosystms has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 7.19 M. Net Loss for the year was (50.08 M) with loss before overhead, payroll, taxes, and interest of (24.77 M).
T2 Biosystms currently holds about 13.21 M in cash with (48.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 74.0% of the company shares are owned by institutional investors

T2 Biosystms Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of TTOO Pink Sheet often depends not only on the future outlook of the current and potential T2 Biosystms' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. T2 Biosystms' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding2.6 M
Cash And Short Term Investments15.7 M

T2 Biosystms Technical Analysis

T2 Biosystms' future price can be derived by breaking down and analyzing its technical indicators over time. TTOO Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of T2 Biosystms. In general, you should focus on analyzing TTOO Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

T2 Biosystms Predictive Forecast Models

T2 Biosystms' time-series forecasting models is one of many T2 Biosystms' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary T2 Biosystms' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about T2 Biosystms

Checking the ongoing alerts about T2 Biosystms for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for T2 Biosystms help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
T2 Biosystms generated a negative expected return over the last 90 days
T2 Biosystms has high historical volatility and very poor performance
T2 Biosystms has some characteristics of a very speculative penny stock
T2 Biosystms has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 7.19 M. Net Loss for the year was (50.08 M) with loss before overhead, payroll, taxes, and interest of (24.77 M).
T2 Biosystms currently holds about 13.21 M in cash with (48.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 74.0% of the company shares are owned by institutional investors

Other Consideration for investing in TTOO Pink Sheet

If you are still planning to invest in T2 Biosystms check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the T2 Biosystms' history and understand the potential risks before investing.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
CEOs Directory
Screen CEOs from public companies around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Volatility Analysis
Get historical volatility and risk analysis based on latest market data